[Enterosorption in chronic enterocolitis].
Polyfepan, a sorbent, included in the complex of therapeutic measures for the patients with exacerbations of chronic enterocolitis, has considerably reduced the terms necessary to arrest the major symptoms of the condition vs. the reference group. The effect was the most manifest when the sorbent was combined with polyenzyme drugs. Laboratory tests and rat experiments have helped validate polyfepan action as the agent binding microorganisms and their toxins on its surface and fixing the enzyme vector at the site of the pathologic process.
Shchedrunov
V V
VV
Solomennikov
A V
AV
Ismailov
M T
MT
Zhuravskaia
I M
IM
Lapteva
E N
EN
Beliakov
N A
NA
D000327:Adsorption; D000328:Adult; D000992:Antitoxins; D001424:Bacterial Infections / Q000188:drug therapy*; D002908:Chronic Disease; D004760:Enterocolitis / Q000188:drug therapy*; D004768:Enterotoxins / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D008031:Lignin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D000992:Antitoxins; D004768:Enterotoxins; C056995:polyfepan; D008031:Lignin
Enterosorbtsiia pri khronicheskom énterokolite.